Report for: Breast-Cancer Risk in Families with Mutations in PALB2

Title	Breast-Cancer Risk in Families with Mutations in PALB2
Published in	New England Journal of Medicine, August 2014
DOI	10.1056/nejmoa1400382
Pubmed ID	25099575
Authors	Antonis C. Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira, Eva Tomiak, Susan L. Neuhausen, Zhi L. Teo, Sofia Khan, Kristiina Aittomäki, Jukka S. Moilanen, Clare Turnbull, Sheila Seal, Arto Mannermaa, Anne Kallioniemi, Geoffrey J. Lindeman, Saundra S. Buys, Irene L. Andrulis, Paolo Radice, Carlo Tondini, Siranoush Manoukian, Amanda E. Toland, Penelope Miron, Jeffrey N. Weitzel, Susan M. Domchek, Bruce Poppe, Kathleen B.M. Claes, Drakoulis Yannoukakos, Patrick Concannon, Jonine L. Bernstein, Paul A. James, Douglas F. Easton, David E. Goldgar, John L. Hopper, Nazneen Rahman, Paolo Peterlongo, Heli Nevanlinna, Mary-Claire King, Fergus J. Couch, Melissa C. Southey, Robert Winqvist, William D. Foulkes, Marc Tischkowitz
Abstract	Germline loss-of-function mutations in PALB2 are known to confer a predisposition to breast cancer. However, the lifetime risk of breast cancer that is conferred by such mutations remains unknown.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 237 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	92	39%
United Kingdom	18	8%
Spain	15	6%
Canada	6	3%
Italy	5	2%
Australia	3	1%
France	3	1%
Venezuela, Bolivarian Republic of	3	1%
Belgium	2	<1%
Other	18	8%
Unknown	72	30%

Demographic breakdown

Type	Count	As %
Members of the public	142	60%
Scientists	51	22%
Practitioners (doctors, other healthcare professionals)	39	16%
Science communicators (journalists, bloggers, editors)	5	2%

Mendeley readers

The data shown below were compiled from readership statistics for 486 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United States	4	<1%
Canada	3	<1%
Germany	2	<1%
United Kingdom	2	<1%
Chile	1	<1%
France	1	<1%
Argentina	1	<1%
Finland	1	<1%
Unknown	471	97%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	105	22%
Researcher	77	16%
Student > Ph. D. Student	66	14%
Other	47	10%
Student > Bachelor	46	9%
Other	94	19%
Unknown	51	10%

Readers by discipline	Count	As %
Medicine and Dentistry	154	32%
Biochemistry, Genetics and Molecular Biology	115	24%
Agricultural and Biological Sciences	104	21%
Nursing and Health Professions	7	1%
Pharmacology, Toxicology and Pharmaceutical Science	7	1%
Other	27	6%
Unknown	72	15%

Attention Score in Context

This research output has an Altmetric Attention Score of 832. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2019.

All research outputs

#11,144

of 17,455,239 outputs

Outputs from New England Journal of Medicine

#543

of 28,291 outputs

Outputs of similar age

#96

of 200,716 outputs

Outputs of similar age from New England Journal of Medicine

of 352 outputs

Altmetric has tracked 17,455,239 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 28,291 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 92.1. This one has done particularly well, scoring higher than 98% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.

We're also able to compare this research output to 352 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.

Breast-Cancer Risk in Families with Mutations in PALB2

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context